Iftikhar kullo md1/27/2024 This scientific statement outlines current best practices for delivering cardiovascular genetic evaluation and care in both the pediatric and the adult settings, with a focus on team member expertise and conditions that most benefit from genetic evaluation. Kullo works with one thousand doctors including Dr. Kullo has two officesin Minnesota where he specializes in Cardiology. This emerging subspecialty may ultimately require a new cardiovascular subspecialist, the genetic cardiologist, equipped with these combined skills, to permit interpretation of genetic variation within the context of phenotype and to extend the utility of genetic testing. Iftikhar Kullo graduated from Other in 1991. The integration of clinical cardiovascular findings, including those obtained from physical examination, imaging, and functional assessment, with genetic information allows for improved diagnosis, prognostication, and cascade family testing to identify and to manage risk, and in some cases to provide genotype-specific therapy. With these advances and challenges, there is a need for specialized programs combining both cardiovascular medicine and genetics expertise. He completed residency training in Internal Medicine, including the Clinician. Emerging challenges include interpretation of genetic test results and the evaluation, counseling, and management of genetically at-risk family members who have inherited pathogenic variants but do not yet manifest disease. Iftikhar Kullo is a Professor of Medicine at Mayo Clinic Rochester, MN. There have also been great advances in clinical diagnostic methods, as well as in therapies to ameliorate symptoms, slow progression of disease, and mitigate the risk of adverse outcomes. Cardiovascular genetics is a rapidly evolving subspecialty within cardiovascular medicine, and its growth is attributed to advances in genome sequencing and genetic testing and the expanding understanding of the genetic basis of multiple cardiac conditions, including arrhythmias (channelopathies), heart failure (cardiomyopathies), lipid disorders, cardiac complications of neuromuscular conditions, and vascular disease, including aortopathies. Actionability Cardiovascular CDWG Complex Disease Familial Hypercholesterolemia. Kullo's Atherosclerosis and Lipid Genomics Lab have vital roles in advancing cardiovascular disease research.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |